Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission-Reference-Cited by-同舟云学术

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

Published:2004-09-10 Issue:12 Volume:11 Page:819-829
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Lichtenstein Drew L,Wold William S M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700765.pdf

Reference108 articles.

1. Rowe WP, Huebner RJ, Gillmore LK, Parrott RH, Ward TG . Isolation of a cytopathic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953;84:570–573.

2. Hilleman MR, Werner JH . Recovery of new agents from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954;85:183–188.

3. Huebner RJ, Rowe WP, Ward TG, Parrott RH, Bell JA . Adenoidal—pharyngoconjunctival agents. N Engl J Med. 1954;251:1077–1086.

4. Horwitz MS . Adenoviruses. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2001: 2301–2326.

5. Commission on Acute Respiratory Disease. Experimental transmission of minor respiratory illness to human volunteers by filter-passing agents. I. Demonstration of two types of illness characterized by long and short incubation periods and different clinical features. J Clin Invest. 1947;26:957–982.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety;International Journal of Molecular Sciences;2023-11-20

2. Icosahedral gold nanoparticles decorated with hexon protein: a surrogate for adenovirus serotype 5;Analytical and Bioanalytical Chemistry;2022-10-24

3. Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-DΔNΔC Gene Therapy Containing Residual Replication-Competent Adenoviruses;Human Gene Therapy;2021-07-01

4. Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2;Vaccines;2021-05-03

5. The infectivity of progeny adenovirus in the presence of neutralizing antibody;Journal of General Virology;2021-04-12